6 Results for "

THZ1

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "THZ1" in MCE Product Catalog:

93
93 Publications Verification
Art. -Nr.: HY-80013
CAS. Nr.: 1604810-83-4
Target:  

CDK

Forschungsgebiete:  

Cancer

THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM. THZ1 also inhibits the closely related kinases CDK12 and CDK13 and downregulates MYC expression [1] .
loading...
    loading...
93
93 Publications Verification
Art. -Nr.: HY-80013A
Target:  

CDK

Forschungsgebiete:  

Cancer

THZ1 Hydrochloride is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM. THZ1 Hydrochloride also inhibits the closely related kinases CDK12 and CDK13 and downregulates MYC expression [1] .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-19988
CAS. Nr.: 1621523-07-6
Target:  

CDK

Forschungsgebiete:  

Cancer

THZ1-R is a non-cysteine reactive analog of THZ1 which displays diminished activity for CDK7 inhibition. THZ1-R binds to CDK7 with a Kd of 142 nM.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-128867
CAS. Nr.: 1604811-14-4
Reinheit:  98.06%
Target:  

CDK

Forschungsgebiete:  

Cancer

bio-THZ1 is a biotinylated version of THZ1 and binds irreversibly to CDK7. THZ1 is a selective and potent covalent CDK7 inhibitor with an IC50 of 3.2 nM [1].
loading...
    loading...
Art. -Nr.: HY-116871
CAS. Nr.: 1957202-71-9
Reinheit:  98.67%
Target:  

CDK

Forschungsgebiete:  

Cancer

YKL-1-116 is a selective and covalent inhibitor of Cdk7. YKL-1-116 does not target Cdk9, Cdk12, or Cdk13. YKL-1-116 is more potent than THZ1 (HY-80013) toward both Cdk7 WT and Cdk7 as, although Cdk7 as is relatively resistant to this compound as well [1].
loading...
    loading...
Art. -Nr.: HY-80013B
CAS. Nr.: 2095433-94-4
Target:  

CDK

Forschungsgebiete:  

Cancer

(E/Z)-THZ1 dihydrochloride is a selective inhibitor of CDK7 with an IC50 of 3.2 nM. (E/Z)-THZ1 dihydrochloride has antiproliferative effect [1] .
loading...
    loading...